| Sep 17 2015 |
FDA Releases Two Final Food Safety Rules: What You Need to Know |
Mintz |
| Sep 17 2015 |
De Minimis Lost Sales Dooms Robinson-Patman Claims |
ArentFox Schiff LLP |
| Sep 16 2015 |
3D-Printed Prescription Drugs a Huge Stride Forward for Personalized Medicine |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Sep 16 2015 |
New Business Opportunities for Pharmacies: Do You Have the Required Licenses? |
Much Shelist, P.C. |
| Sep 16 2015 |
Proposed Rule Would Amend Federal “Common Rule” Requirements |
Covington & Burling LLP |
| Sep 16 2015 |
Diabetes Drug Januvia Linked to Severe Joint Pain |
Stark & Stark |
| Sep 16 2015 |
Mandatory GMO Labeling Quashed Under House Bill |
Varnum LLP |
| Sep 16 2015 |
CDRH Schedules Next Generation Sequencing Workshops |
Covington & Burling LLP |
| Sep 14 2015 |
General Court Makes Interim Order to Protect Confidentiality in Pari Pharma Transparency Case |
Covington & Burling LLP |
| Sep 11 2015 |
FDA Warning Letter Says Vegan Mayonnaise Can’t be Labeled Mayo |
Armstrong Teasdale |
| Sep 11 2015 |
FSMA Final Rules Released Addressing Human and Animal Food |
Michael Best & Friedrich LLP |
| Sep 11 2015 |
Legislative Action to Remove Microbeads from Personal Care Products Intensifies |
Mintz |
| Sep 11 2015 |
EPA Proposes New Rules for Pharmaceutical Wastes That Qualify as RCRA Hazardous Wastes |
Beveridge & Diamond PC |
| Sep 11 2015 |
HRSA “Drops” its Latest 340B Omnibus Guidance – Don’t Stop Believin’ in Drug Discounts |
Squire Patton Boggs (US) LLP |
| Sep 10 2015 |
Canadian Government Launches Xarelto Investigation |
Stark & Stark |
| Sep 10 2015 |
Highest EU Court: REACH SVHC Thresholds Apply at Component – Not Product – Level |
Beveridge & Diamond PC |
| Sep 10 2015 |
Clinical Trials As Prior Art: PTAB Denies Bass IPR Petition With Only A "Hope" of Efficacy |
Foley & Lardner LLP |
| Sep 10 2015 |
FDA Releases Initial FSMA Final Rules |
Armstrong Teasdale |
| Sep 10 2015 |
FDA Releases Long-Awaited Biological Naming Draft Guidance and Proposed Rule |
McDermott Will & Emery |
| Sep 8 2015 |
What’s in a Name? When You’re Selling a Food with an Established Federal Standard of Identity, a Whole Lot! |
Mintz |
| Sep 8 2015 |
Patent Trial and Appeal Board Boots Bass Tecfidera IPR On The Merits |
Foley & Lardner LLP |
| Sep 4 2015 |
Wine Seller Victory in Illinois Qui Tam Lawsuit |
Horwood Marcus & Berk Chartered |
| Sep 4 2015 |
Sandoz Launches First Biosimilar Drug in U.S. |
Schwegman, Lundberg & Woessner, P.A. |
| Sep 4 2015 |
Marijuana-Legalization Efforts and Their Impact on the Presidential Race |
Jackson Lewis P.C. |
| Sep 3 2015 |
NLRB Says Beer Dealer’s Refusal-To-Drug-Test Firing Doesn’t Mix With “Weingarten Rights” |
Jackson Lewis P.C. |
| Sep 3 2015 |
Another Claim Bites the Dust left by Teva v. Sandoz |
Schwegman, Lundberg & Woessner, P.A. |
| Sep 3 2015 |
Long-Awaited Notice of Proposed Rulemaking for Federal Policy for the Protection of Human Subjects Released |
Faegre Drinker |
| Sep 3 2015 |
Update in Amgen v. Sandoz re: Biosimilar Applications |
Michael Best & Friedrich LLP |
| Sep 2 2015 |
Minnesota Federal Court Finds “Field Preemption” of Minnesota Drug Testing Statute |
Jackson Lewis P.C. |
| Sep 1 2015 |
Makers’ Mark Two: Bourbon Distiller Slips another “Handmade” False Advertising Suit |
Proskauer Rose LLP |
| Sep 1 2015 |
Wait Continues for Release of First FSMA Final Rules |
Armstrong Teasdale |
| Sep 1 2015 |
FDA’s New Four-Letter Guidance on Biosimilars |
Mintz |
| Aug 31 2015 |
Getting Serious about Palcohol: Powdered Alcohol |
Faegre Drinker |
| Aug 31 2015 |
An Update on Biosimilar Activity in the U.S. |
Michael Best & Friedrich LLP |
| Aug 30 2015 |
Another FTC Conduct Case to Bolster Generic Drug Competition: Pharmaceuticals Charged with Illegal Non-Compete for Generic ADHD Drug Sales |
Mintz |
